Advised on a RUB 15.5 bn (approx. USD 240 m) investment sale of a controlling stake in Obolenskoe Pharm, a leading Russian pharmaceutical company. The stake was acquired by Sistema (LSE: SSA, MOEX: AFKS), a large Russian diversified holding company, jointly with VTB Bank from Alvansa Ltd, a holding company controlled by Gazprombank and UFG Private Equity. We represented the sellers in the main sale of the business and acted for OBL Pharm’s management team in its negotiations with investors with respect to the shareholder deal.